"The manufacturer must assume responsibility for the quality of the...
Category:
Health
Latest
774 fresh Covid cases in India,active cases stands at 4,187
Two deaths -- one each from Tamil Nadu and Gujarat -- were reported...
General insurance industry’s premium rises 15% to Rs 25k in Dec 2023
In a move that supported the growth of the industry, New India...
Moody’s cuts India growth forecast for 2021 to 9.6 pc
“Mobility and economic activity will likely accelerate in the second half of the year as the pace of vaccinations pick up. The government recently announced a strategy to centralise vaccine procurement in order to boost vaccinations, which if successful, will support the economic recovery,” it added.
Men took bigger jobs hit in pandemic across euro zone: ECB study
Men accounted for more than 60% of the jobs losses last year, while in terms of hours worked they suffered more than two-thirds of the overall drop, the ECB said in an Economic Bulletin article.
With women heavily represented in the leisure and hospitality sector, some economists and even ECB officials warned that women were at risk of losing more, but the study suggests that women found new work more easily then men.
States” reopening strategy not ”prudent” as vaccination coverage low in many places: Report
According to the report, re-opening has commenced at a faster pace than it had anticipated as states have focused on declining test positivity rates as the guiding factor for easing measures rather than the share of population vaccinated.
9 months after lockdowns, US births see biggest decline since 1973
Coupled with the more than half a million Americans who have died from Covid-19, the drop in births will have long-term consequences for the population growth.
Delta variant ‘greatest threat’ to US’ COVID-19 efforts: Dr Fauci
”Similar to the situation in the UK, the Delta variant is currently the greatest threat in the US to our attempt to eliminate COVID-19,” Fauci told reporters during a virtual news conference here.
However, the “good news” is that the US vaccines are effective against the Delta variant, said Fauci, the head of the National Institutes of Allergy and Infectious Diseases (NIAID).
Private hospitals to log 15-17% revenue growth in FY22: Crisil
“While the second wave lashed again in April, the first quarter this fiscal will be sharply better on-year, with occupancy of 75 per cent, almost double on-year. This will be largely on account of a surge in Covid-19 treatments more than offsetting the deferral of elective surgeries and outpatient footfalls,” Crisil Ratings Senior Director Manish Gupta said.
As the second wave recedes in the second quarter, Crisil expects pent-up demand for non-Covid treatments to rebound and support occupancy, he added.
Some blood pressure-lowering medicines linked to less memory decline in older adults: Study
“Hypertension occurs decades prior to the onset of dementia symptoms, affecting blood flow not only in the body but also to the brain,” A. Nation said.
The author added, “Treating hypertension is likely to have long-term beneficial effects on brain health and cognitive function later.”
IRDAI allows home treatment as add-on cover in health insurance
Reacting to the development, Liberty General Insurance Ltd’s CEO and Whole Time Director Roopam Asthana told IANS that the “add-on cover has to be priced right taking into account the data and possible scenarios”.
Though the insurers will save on huge daily hospital room charges, the doctor and nurse fee may be on slightly on the higher side then what a hospital charges.
World Bank, African Union join forces to expand access to Covid-19 vaccines
Strive Masiyiwa, African Union special envoy, said the collaboration between the World Bank and African institutions such as the Africa Import Export Bank and the Africa Centre for Disease Control would provide the capacity to vaccinate at least 400 million people or 30% of the total African population.
Mongolia,Bahrain and Seychelles battling a surge in Covid-19 infections despite administering Chinese vaccine
All three put their faith, at least in part, in easily accessible Chinese-made vaccines, which would allow them to roll out ambitious inoculation programmes at a time when much of the world was going without.
But instead of freedom from the coronavirus, all three countries are now battling a surge in infections.China kicked off its vaccine diplomacy campaign last year by pledging to provide a shot that would be safe and effective at preventing severe cases of Covid-19.